Loading clinical trials...
Loading clinical trials...
Efficacy Evaluation of Umbilical Cord Blood-derived Mononuclear Cells in the Treatment of Refractory Neonatal Diseases
Conditions
Interventions
Mononuclear cells
Mild hypothermia therapy
+2 more
Locations
1
China
Qilu Children's Hospital of Shandong University
Jinan, Shandong, China
Start Date
April 1, 2022
Primary Completion Date
May 30, 2024
Completion Date
April 30, 2025
Last Updated
May 24, 2024
NCT07197944
NCT06448780
NCT06925360
NCT05561647
NCT06973304
NCT06110481
Lead Sponsor
Shandong Qilu Stem Cells Engineering Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions